Paratek Pharmaceuticals Inc expected to post earnings of 9  cents a share - Earnings Preview

Paratek Pharmaceuticals

10/03/2023 15:08

* Paratek Pharmaceuticals Inc  PRTK.OQ   PRTK.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 16. 
    * The Boston Massachusetts-based  company is expected to
report  a
99.6% increase in revenue to $63.455 million from $31.8 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Paratek
Pharmaceuticals
Inc is for earnings of 9 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $20​, above​ its last closing price
of $1.69. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.31       -0.29      -0.38     Missed  -31
 Jun. 30 2022  -0.33       -0.34      -0.33     Beat    2
 Mar. 31 2022  -0.35       -0.35      -0.35     Met     0​
 Dec. 31 2021  -0.62       -0.41      -0.66     Missed  -60
 ​​Sep.        -0.44       -0.45      -0.37     Beat    17.8
 30 2021                                                
 Jun. 30 2021  0.35        0.32       0.20      Missed  -36.5​
 Mar. 31 2021  -0.40       -0.38      -0.39     Missed  -2.1
 Dec. 31 2020  -0.12       -0.04      -0.60     Missed  -1,233
                                                        .3
 This summary was machine generated March 10 at 15:08 GMT.  All
figures in US dollars  unless otherwise stated